glp-1 pet scan imaging news Brain of the Receptor in Obesity Using 68Ga-NODAGA-Exendin-4 Glucagon-like Peptide 1–Receptor Scans to
Description
White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F: EXAMINE Investigators
Passing the baton in class B GPCRs: peptide hormone activation via helix induction
The data suggest that the decrease in lean mass is comparable to that seen with bariatric surgery, and exercise capacity generally improves following bariatric surgery (76)
Other medications within these classes have demonstrated weight loss efficacy but are not FDA approved for weight loss (eg, medications approved for diabetes that can induce weight loss) and therefore are not included in the table
Despite their therapeutic advantages, GLP-1-RAs have complicated economic and healthcare consequences
